Skip to main content

Peer Review reports

From: Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study

Original Submission
5 Mar 2013 Submitted Original manuscript
8 Sep 2013 Author responded Author comments - Christopher Jackson
18 May 2013 Reviewed Reviewer Report - Fotios Loupakis
10 Aug 2013 Reviewed Reviewer Report - Guang-Hai Dai
Resubmission - Version 2
8 Sep 2013 Submitted Manuscript version 2
Publishing
23 Sep 2014 Editorially accepted
2 Oct 2014 Article published 10.1186/1471-2407-14-737

You can find further information about peer review here.

Back to article page